The trading price of Beta Bionics Inc (NASDAQ:BBNX) closed lower on Friday, March 21, and closing at $15.10, -3.76% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $14.95 and $15.74. In examining the 52-week price action we see that the stock hit a 52-week high of $24.50 and a 52-week low of $13.64. Over the past month, the stock has lost -27.65% in value.
Beta Bionics Inc, whose market valuation is $654.28 million at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -1.22 per share this quarter, however they have predicted annual earnings per share of -2.04 for current year and -1.65 for next year.
Analysts have forecast the company to bring in revenue of 20.19M for the current quarter, with the likely lows of 19.1M and highs of 20.52M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 64.88M.
A quick review shows that BBNX’s price is currently -12.30% off the SMA20 and -22.70% off the SMA50. The RSI metric on the 14-day chart is currently showing 31.92, and weekly volatility stands at 8.45%. When measured over the past 30 days, the indicator reaches 9.18%. Beta Bionics Inc (NASDAQ:BBNX)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 1.43.
To see how Beta Bionics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: BBNX stock’s performance was -3.76% in the latest trading.
An evaluation of the daily trading volume of Beta Bionics Inc (NASDAQ:BBNX) indicates that the 3-month average is 578.37K. However, this figure has increased over the past 10 days to an average of 0.74.
Currently, records show that 42.86 million of the company’s shares remain outstanding. The insiders hold 18.65% of outstanding shares, whereas institutions hold 38.04%. The stats also highlight that short interest as of 2025-02-28, stood at 0.95 million shares, resulting in a short ratio of 1.8 at that time. It is noteworthy that short shares in February were up slightly from the previous month’s figure, which was 0.21 million. However, since the stock’s price has seen -36.10% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
